Search hospitals > Massachusetts > Boston

Tufts Medical Center

Claim this profile
Boston, Massachusetts 02111
Global Leader in Heart Failure
Global Leader in Breast Cancer
Conducts research for Pulmonary Arterial Hypertension
Conducts research for Pulmonary Hypertension
Conducts research for Multiple Myeloma
863 reported clinical trials
61 medical researchers
Photo of Tufts Medical Center in BostonPhoto of Tufts Medical Center in BostonPhoto of Tufts Medical Center in Boston

Summary

Tufts Medical Center is a medical facility located in Boston, Massachusetts. This center is recognized for care of Heart Failure, Breast Cancer, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Multiple Myeloma and other specialties. Tufts Medical Center is involved with conducting 863 clinical trials across 955 conditions. There are 61 research doctors associated with this hospital, such as Jason Law, Katina M. Robison, Nicholas S Hill, MD, and Andreas K. Klein.

Area of expertise

1Heart Failure
Global Leader
Tufts Medical Center has run 54 trials for Heart Failure. Some of their research focus areas include:
Stage III
2Breast Cancer
Global Leader
Tufts Medical Center has run 45 trials for Breast Cancer. Some of their research focus areas include:
ER positive
Stage II
Stage I

Top PIs

Clinical Trials running at Tufts Medical Center

Breast Cancer
Multiple Myeloma
Lung Cancer
Cancer
Testicular cancer
Pancreatic Cancer
Brain Tumor
Amyloidosis
Multiple Sclerosis
Glioblastoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Tufts Medical Center?
Where is Tufts Medical Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does Tufts Medical Center accept?
What awards or recognition has Tufts Medical Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security